Acute Dermal Irritation Research Articles

Azelaic acid-based lyotropic liquid crystals gel for acne vulgaris: Formulation optimization, antimicrobial activity and dermatopharmacokinetic study

The proposed study aimed to develop a topical gel containing azelaic acid (AZA)-based lyotropic liquid crystals (LLCs) for the treatment of acne vulgaris. AZA-based LLCs were optimized by varying Poloxamer-407 and polyvinyl alcohol concentration using a central composite design, which showed that both independent variables had a significant effect on the formulation. The highest desirable trial of AZA-based LLCs (Batch-7) containing 300 mg poloxamer-407 and 100 mg polyvinyl alcohol depicted the particle size, zeta potential, and entrapment efficiency of 184.2 nm, −16.1 mV, and 79.96 %, respectively. TEM images confirmed the globular vesicles of LLCs, and ATR-FTIR and DSC results confirmed the compatibility of formulation excipients. In vitro, the release of AZA, AZA-based LLCs, AZA-based LLC gel, and marketed gel showed a release of 23.29, 95.24, 91.07 and 59.88 %, respectively, after 24 h in phosphate buffer pH 6.8. Ex vivo release of AZA-based LLC gel displayed an 86.56 % release after 24 h. The antimicrobial activity of AZA-based LLC gel exhibited a comparable efficacy with marketed gel against Cutibacterium acnes, Staphylococcus epidermis and Staphylococcus aureus. The acute dermal irritation study indicated excellent safety and skin compatibility of AZA-based LLC gel without any erythema and edema. The dermatopharmacokinetic study displayed an enhanced drug retention for AZA-based LLC gel (146.121 ± 21.13 µg/cm2) than marketed gel (58.58 ± 15.95 µg/cm2) in the dermal layer, which would improve its therapeutic effect. These outcomes proved that AZA-based LLC gel has the potential to enhance skin penetration and retention for effective management of acne vulgaris.

Acute dermal irritation and skin sensitization study of mesoporous antibacterial bioactive glass microsphere impregnated surgical cotton gauze dressing material on rabbits and guinea pigs

Acute dermal irritation and skin sensitization study of mesoporous antibacterial bioactive glass microsphere impregnated surgical cotton gauze dressing material on rabbits and guinea pigs

Development of PU foam dressings loaded with extract of Plectranthus amboinicus for burn wound healing

Objective To develop Plectranthus amboinicus extract loaded Polyurethane foam dressing for burn wound healing. Significance Plectranthus amboinicus is traditionally used as an anti-inflammatory and wound-healing agent. Its incorporation in a PU foam dressing will offer the dual benefits of foam dressing as well as the healing potential of P. amboinicus. Methods PU foam dressings were prepared and loaded with P. ambionicus leaf extract (PAE). The dressings were prepared with varying concentrations (0.5–2%) of extract along with Toluene diisocyanate, polypropylene glycol (PPG), and liquid paraffin. The dressings were characterized by Scanning Electron Microscopy and evaluated for Moisture Vapor Transmission Rate, absorption rate, porosity, and mechanical strength followed by in vivo burn wound-healing studies in comparison to a marketed dressing. Results The MVTR was found to be optimum in formulations FD2-FD4 with values ranging from 2068.06 ± 0.99 to 2095.00 ± 0.25 g/m2/day. Absorption rate was found to be between 1.27 ± 0.01, 1.31 ± 0.00, and 1.30 ± 0.02 g/cm2 for formulations FD2-FD4. Formulations FD1, FD2, FD3, FD4 showed better porosity when compared to other formulations. Formulation FD4 was further characterized by micro-CT and a porosity of 46.32% was obtained. Tensile strength measurement indicated that the selected formulations were flexible enough to withstand regular handling during dressing changes. Acute dermal irritation performed on rabbits showed no irritation, erythema, eschar, and edema. In vivo wound-healing studies performed on albino wistar rats showed that the FD4 formulation has better wound healing property. Conclusion Plectranthus ambionicus-loaded PU foam dressing demonstrated promising burn wound-healing potential

Wound Healing Effect of Lippia sidoides and Myracrodruon urundeuva Nanogel.

Wound healing is a natural regenerative response to tissue injury and the conventional treatments consists of the use wound dressings with local administration of medicines, but, in some cases, are only partially effective and limited by toxicity or ineffective anti-microbial protection. Medicinal plants such as Lippia sidoides and Myracrodruon urundeuva have shown interesting pharmacological activities, allied to this, the association of these medicinal plants and nanotechnology, could mean an advantage in relation to classical approach. This study investigated the effect of a nanogel loaded with Lippia sidoides essential oil and Myracrodruon urundeuva extract (NAA) in an excisional wound healing model in rats. Animals were anesthetized and skin wounds were made using a metal punch. The groups were treated with vehicle, NAA or collagenase gel, for 7, 14 or 21 days and then sacrificed for tissue analysis. NAA did not show acute dermal irritation, further significantly reduced (p<0.05) the final wound area, accelerated the wound contraction and organization of collagen in the group treated for 14 days. The data presented here demonstrate the therapeutic potential for the use of nanotechnology associated with medicinal plants and provides evidence that corroborate with the use of L. sidoides and M. urundeuva as healing medicinal plants.

An Integrated Computational and Experimental Approach to Formulate Tamanu Oil Bigels as Anti-Scarring Agent.

Tamanu oil has traditionally been used to treat various skin problems. The oil has wound-healing and skin-regenerating capabilities and encourages the growth of new skin cells, all of which are helpful for fading scars and hyperpigmentation, as well as promoting an all-around glow. The strong nutty odor and high viscosity are the major disadvantages associated with its application. The aim of this study was to create bigels using tamanu oil for its anti-scarring properties and predict the possible mechanism of action through the help of molecular docking studies. In silico studies were performed to analyze the binding affinity of the protein with the drug, and the anti-scarring activity was established using a full-thickness excision wound model. In silico studies revealed that the components inophyllum C, 4-norlanosta-17(20),24-diene-11,16-diol-21-oic acid, 3-oxo-16,21-lactone, calanolide A, and calophyllolide had docking scores of -11.3 kcal/mol, -11.1 kcal/mol, -9.8 kcal/mol, and -8.6 kcal/mol, respectively, with the cytokine TGF-β1 receptor. Bigels were prepared with tamanu oil ranging from 5 to 20% along with micronized xanthan gum and evaluated for their pH, viscosity, and spreadability. An acute dermal irritation study in rabbits showed no irritation, erythema, eschar, or edema. In vivo excisional wound-healing studies performed on Wistar rats and subsequent histopathological studies showed that bigels had better healing properties when compared to the commercial formulation (MurivennaTM oil). This study substantiates the wound-healing and scar reduction potential of tamanu oil bigels.

Melanogenic effects of 5-demethylnobiletin on mouse model of chemical-induced vitiligo

BackgroundA phytochemical 5-demethylnobiletin from Citrus reticulata Blanco has a broad spectrum of pharmacological effects on anti-inflammatory, cardiovascular and neuroprotective effects, however, its in vivo effect on depigmentation remains unknown. ObjectiveTo investigate how 5-demethylnobiletin regulates melanogenesis, both in vitro and in vivo experiments were conducted to evaluate its efficacy and mechanisms in human epidermal melanocyte and mice model of chemical-induced vitiligo. MethodsC57BL/6 mice were induced with 1% hydroquinone (HQ) to shaved dorsal skin and applied with 5-demethylnobiletin or 8-methoxypsoralen (8-MOP, positive control). Melanin contents measurement, immunohistochemistry, Fontana-Masson and HE histological analysis were used to determine melanin contents in follicles. q-PCR, Western blot, dichlorofluorescein (DCF) assay and computational docking were adopted to investigate the molecular mechanisms of 5-demethylnobiletin in the vitiligo mice model. Besides, acute dermal irritation test was conducted to evaluate the biological safety of 5-demethylnobiletin in mice. Results5-demethylnobiletin possessed in vitro anti-oxidative effect, significantly increased melanin content in hair and ameliorated hypopigmentation in mice. The expression level of melanogenesis-related genes such as MITF, tyrosinase, Trp-1 and Trp-2 were significantly upregulated in 5-demethylnobiletin-treated groups. Molecular docking results support that 5-demethylnobiletin is able to bind to tyrosinase, the key enzyme for regulating melanogenesis, suggesting the potential molecular target of 5-demethylnobiletin. Conclusions5-demethylnobiletin has potential therapeutic effect on delaying the onset of depigmentation in vivo, lessened depigmentation incidence which contributes to melanogenesis. The newly revealed biological activity indicates 5-demethylnobiletin may be a potential natural pharmaceutical for the treatment and prevention of chemical-induced depigmentation disorders, and as the components for anti-gray hair products.

Formulation development and characterization of luliconazole loaded−mesoporous silica nanoparticles (MCM−48) as topical hydrogel for the treatment of cutaneous candidiasis

The conventional formulation of luliconazole (LCZ) faces challenges such as poor solubility and limited skin retention upon application. Therefore, the focus of this research was to develop and characterize mesoporous silica nanoparticles (MSN) that can effectively deliver luliconazole for the treatment of cutaneous candidiasis fungal infection.The MSNs were optimized by central composite design and synthesized using the sol−gel method. Factors such as stirring time and surfactant ratio were varied to investigate their impact on particle size and Polydispersity index (PDI). Subsequently, the MSN surface was functionalized with both amine (positively charged) and phosphonate groups (negatively charged) using 3-aminopropyltriethoxysilane (APTES) and 3trihydroxysilyl propyl methylphosphonate (THMP).The efficacy of the optimized luliconazole−loaded MSNs was evaluated through various comparative studies, including in-vitro and in-vivo antifungal assessments, ex-vivo permeation and skin retention experiments, acute dermal irritation tests, and histopathological analysis. These evaluations were compared with the pure drug and a commercially available formulation.The optimized MSNs exhibited high porosity and spherical particle sizes ranging from 300 to 400 nm. They demonstrated excellent physical and chemical stability, indicating compatibility between the drug and the MSN structure. The successful loading of luliconazole into the nanopores of the MSNs was confirmed through Brunauer Emmett Teller (BET) analysis.The luliconazole−loaded MSN (LCZ−MSN) gel exhibited a controlled release profile, sustaining drug release for up to 24 h. The solubility of the drug was 12 times higher compared to the free form, and the MSNs enhanced skin retention by six−fold compared to the pure drug. In an in-vivo cutaneous candidiasis rat model, the enhanced efficacy of the MSNs was evident, highlighting the potential of this innovative approach for controlled release and solubility enhancement of poorly soluble drugs, with no observed skin irritation.Overall, this research showcases the potential of mesoporous silica nanoparticles as a promising approach for controlled delivery and improved solubility of poorly soluble drugs like luliconazole, thereby addressing the challenges associated with conventional formulations and offering a novel strategy for treating cutaneous candidiasis fungal infection.

THE EFFECT OF VARIATION CONCENTRATION OF TETRAHYDROHEXAGAMAVUNON-5 (THHGV-5) IN EMULGEL PREPARATION ON ACUTE DERMAL IRRITATION EFFECT AND SUN PROTECTING FACTOR (SPF) VALUE

Objective: A tropical nation experiences intense daytime solar radiation. The likelihood that this condition will result in skin conditions like skin cancer may increase. The skin can be protected as one strategy for coping with this poor potency. Applying various cosmetic products to the skin can provide protection. Due to the antioxidant activity of certain components, various active ingredient types are used in the formulation of those products. A chemical that was created from the structure of curcumin is one of the examples. This substance is referred to as a curcumin analog. THHGV-5 is an analog of curcumin that has strong antioxidant properties. The purpose of this investigation is to ascertain how different Tetrahydropentagamavunon-5 (THHGV-5) concentrations affect the emulgel's sun-protecting factor (SPF) value and irritancy effect. Methods: The three different concentrations of THHGV-5 emulgel are 1.50%, 1.75%, and 2.00%. Then, tests are conducted on the physical qualities (organoleptic, pH, adhesion, dispersiility, and viscosity). The UV spectrophotometric method was used to determine the SPF value of THHGV-5 emulgel in vitro. Regression analysis was used to examine the SPF values from measurements. The acute dermal irritation method was used to measure the Primary Irritation Index (PII) in real-time. The Indonesian Food and Drug Administration's In vivo Non-Clinical Toxicity Test Guidelines are followed by this procedure. PII results were analyzed with Kruskal-Wallis statistical analysis with a 95% confidence level. Results: SPF and PII values will rise as a result of increasing the THHGV-5 content in the formulae. The concentration of THHGV-5 (1.50%, 1.75%, and 2.00%) causes the increase of the SPF values of the formulas (5.76±1.10, 13.03±1.39, and 15.77±0.22) by moderate, maximum, and ultra protection. PII values obtained are significantly different, with a significance level of ≤ 0.05. Conclusion: According to the study's findings, emulgel formulas with higher THHGV-5 concentrations would have higher SPF values and irritant effects. Since a tropical country's SPF recommendation is 15, THHGV-5 with a 2.00% concentration will be able to provide enough protection. However, a study of three different THHGV-5 concentrations (1.50%, 1,75%, and 2.00%) revealed that none of the formulae were skin-safe since they can irritate the skin.

Optimization of 3,4-Dimethoxychalcone and Rutin Containing Gel with Simplex Lattice Design and In Vitro-In Vivo Test as a Sunscreen

3,4-Dimethoxychalcone and rutin, a flavonoid that contains chromophore groups, can absorb UV light and thus can be developed as a sunscreen. The objective of this study was to determine the optimum formula of 3,4-dimethoxychalcone and rutin containing gel, evaluate its physical stability, and activity of 3,4-dimethoxychalcone and rutin gel as a sunscreen through in vitro and in vivo tests. HPMC, CMC-Na, and methylcellulose were formulated into a gel base to obtain good adhesion and a clear appearance gel. Simplex Lattice Design (SLD) with Design Expert software version 10 was utilized to determine the optimum gel formulation. UVA-PF protection, photostability with transpore method, and acute dermal irritation test were performed to evaluate sunscreen activity of 3,4-dimethoxychalcone and rutin gel. The data were analyzed using SPSS version 25. The results showed that the optimum formula for 3,4-dimethoxychalcone-rutin gel consisted of 1.5% HPMC, 1.8% CMC-Na and 0.6% methylcellulose, which showed a pH of 6.96, viscosity of 89.10 dpa.s, and spreadability of 16.30 cm2. The pH, viscosity, and spreadability of base and 3,4-dimethoxychalcone- rutin gel was stable for 4 weeks of storage. The UVA-PF value is 6.48 which according to the FDA is included in the category of a two star (**) sunscreen label. The sunscreen did not exhibit a shift in wavelength after 6 hours of irradiation. Based on the primary irritation test, 3,4-dimethoxychalcone- rutin sunscreen produced zero (0) erythema and edema index. Thus, it did not cause irritation to the skin of experimental animals. Therefore, the gel containing 3,4-dimethoxychalcone and rutin had potential as a sunscreen product based on in vitro-in vivo tests and was safe on animal skin.

The Use of an Ambroxol Solution to Assess Acute Dermal Irritation on Rabbit Skin

Ambroxol can overcome infections due to the presence of biofilms in the body by interfering with the formation of sticky biofilms and reducing biofilm production, so it has the potential to be used in topical preparations for the treatment of infections. This study aimed to measure the irritating effect on the skin of rabbits resulting from the ambroxol solution to assess the safety of the ambroxol solution. The methods refers to BPOM 2020, namely by dabbing 0.5 ml of ambroxol solution on the back skin of rabbits, then covering it with gauze and non-irritant plasters, after 4 hours of cleaning of residues is then observed at 1 , 24, 48 and 72 hours to see whether or not there was an effect of erythema and edema arising from the influence of the experiment, and at the end of the investigation, a histopathological test was carried out. The results of the research are Macroscopically the ambroxol solution did not show any erythema and edema, so the primary irritation index score was obtained for all test solutions with a score of 0. In contrast, in the microscopic irritation test, the score for erythema was 4 and for edema was 3. . From this research, it can be concluded that the ambroxol solution non-irritating to the skin.&#x0D; &#x0D; KEYWORDS: Biofilm, ambroxol solutions, acute irritation test.&#x0D; &#x0D;

Topical Application of Ursolic Acid Cream Ameliorates Imiquimod-induced Plaque Psoriasis in BALB/c Mice

The valued studies of alternative psoriasis treatment options are in a much higher need among the Scientific Community. This study aimed to evaluate the anti-psoriatic activity of ursolic acid cream in imiquimod-induced psoriasis in BALB/c mice. The creams containing ursolic acid, a pentacyclic triterpenoid at percentages of 0.1 and 0.2% were formulated. The pH, spreadability, physical characteristics and acute dermal irritation of the cream were assessed. Animals were grouped into five each having 6 animals. Clobetasol, a topical corticosteroid, was used as the standard. One group was used as control and four groups were treated with the formulated imiquimod cream while receiving treatment. Parameters such as skin inflammation severity, ear thickness, plasma level of interleukins (IL)-17, histology of the back of the skin and spleen weight were evaluated. Erythema and scales were scored on a daily basis with the 0.1 and 0.2% ursolic acid cream significantly ameliorating psoriatic-like symptoms in a manner comparable to clobetasol. Imiquimod-induced epidermal hyperplasia and inflammation were inhibited by topical application of ursolic acid as shown by the results of histopathology. Spleens of the positive control group were larger in comparison with the rest of the groups. BALB/c mice treated with ursolic acid creams exhibited a decrease in the plasma levels of cytokines IL-17 when compared to the positive control group. The result of this study provided an insight that topical application of ursolic acid can be a potential treatment for psoriasis.

Gallic Acid-Loaded Sodium Alginate-Based (Polyvinyl Alcohol-Co-Acrylic Acid) Hydrogel Membranes for Cutaneous Wound Healing: Synthesis and Characterization

Traditional wound dressings often cannot treat wounds caused by bacterial infections or other wound types that are insensitive to these wound treatments. Therefore, a biodegradable, bioactive hydrogel wound dressing could be an effective alternative option. The purpose of this study was to develop a hydrogel membrane comprised of sodium alginate, polyvinyl alcohol, acrylic acid, and gallic acid for treating skin wounds. The newly developed membranes were analyzed using Fourier transform infrared spectroscopy (FTIR), thermogravimetric analysis (TGA), differential scanning calorimetry (DSC) and scanning electron microscopy (SEM), X-ray diffraction analysis (XRD), sol-gel fraction, porosity, mechanical strength, swelling, drug release and data modelling, polymeric network parameters, biodegradation, and antioxidation (DPPH and ABTS) and antimicrobial activity against Gram-positive and negative bacteria. The results revealed that hydrogel membranes were crosslinked successfully and had excellent thermal stability, high drug loading, greater mechanical strength, and exhibited excellent biodegradation. Additionally, the swelling ability and the porosity of the surface facilitated a controlled release of the encapsulated drug (gallic acid), with 70.34% release observed at pH 1.2, 70.10% at pH 5.5 (normal skin pH), and 86.24% at pH 7.4 (wounds pH) in 48 h. The gallic acid-loaded hydrogel membranes showed a greater area of inhibition against Pseudomonas aeruginosa, Staphylococcus aureus, and Escherichia coli bacteria as well as demonstrated excellent antioxidant properties. Based on Franz cell analyses, the permeation flux of the drug from optimized formulations through mice skin was 92 (pH 5.5) and 110 (pH 7.4) μg/cm2·h-1. Moreover, hydrogel membranes retained significant amounts of drug in the skin for 24 h, such as 2371 (pH 5.5) and 3300 µg/cm2 (pH 7.4). Acute dermal irritation tests in rats showed that hydrogel membranes were nonirritating. Hydrogel membranes containing gallic acid could be an effective option for improving wound healing and could result in faster wound healing.

Wound Healing and Anti-Inflammatory Effects of a Newly Developed Ointment Containing Jujube Leaves Extract.

Ziziphus jujuba Mill. (jujube) is a well-known medicinal plant with pronounced wound healing properties. The present study aimed to establish the chemical composition of the lyophilized ethanolic extract from Romanian Ziziphus jujuba leaves and to evaluate the healing and anti-inflammatory properties of a newly developed lipophilic ointment containing 10% dried jujube leaves extract. The ultra-High-Performance Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometry method was used, and 47 compounds were detected, among them the novel epicatechin and caffeic acid. The extract contains significant amounts of rutin (29.836 mg/g), quercetin (15.180 mg/g) and chlorogenic acid (350.96 µg/g). The lipophilic ointment has a slightly tolerable pH, between 5.41-5.42, and proved to be non-toxic in acute dermal irritation tests on New Zealand albino rabbits and after repeated administration on Wistar rats. The ointment also has a healing activity comparable to Cicatrizin (a pharmaceutical marketed product) on Wistar rats and a moderate anti-inflammatory action compared to the control group, but statistically insignificant compared to indomethacin in the rat-induced inflammation test by intraplantar administration of kaolin. The healing and anti-inflammatory properties of the tested ointment are due to phenolic acids and flavonoids content, less because of minor components as apocynin, scopoletin, and isofraxidin.

Sterile thermoresponsive formulations for emergency management of burns

Initial care and treatment of burn injuries significantly influence their healing and appearance. The apt treatment for a burn patient normally depends upon the severity of the burn. This study was intended for the development of thermo-responsive formulations for the emergency management of burns prior to hospitalization.Nano calcium sulfate was prepared by probe sonication and nano copper oxide by thermal decomposition method and subsequently evaluated for particle size and poly-dispersity index. Formulations were prepared with 100 ppm of nano calcium sulphate, nano copper oxide and thermoresponsive polymers such as Poloxamer-407/ Chitosan/chitosan + Sodium β -glycerophosphate in different ratios. The products were evaluated for pH, viscosity and gelation time and those formulations which exhibited optimum viscosity, pH and gelation time were sterilized and evaluated for elemental content, skin irritation potential and in vivo burn healing activity.Nano calcium sulfate and nano copper oxide exhibited an average particle size of 220 nm and 273 nm correspondingly. SEM-EDX of selected formulations showed intense peaks of calcium and copper in all formulations. Acute dermal irritation study carried out on rabbits showed that the formations were non-irritant in nature. The percentage of wound contraction was greater in burn wounds treated with the formulation containing poloxamer-407 when compared to commercial Silverex™ ionic gel and the control group. The healing actvity of the thermoresponsive formulations was supported by histopathological studies.Nano calcium sulfate and nano copper oxide incorporated thermo-responsive formulations with burn wound healing activity were developed successfully.

Acute Dermal and Ocular Irritation Testing of Herbal Shampoos in New Zealand White Rabbits

Abstract: Aim: The objective of the presented study is to evaluate the acute dermal and ocular irritation of herbal shampoos consisting of a mixture of plant extracts. Materials and Methods: Both studies performed using New Zealand white rabbits in accordance with HICS and OECD guidelines respectively. In the cutaneous skin irritation test, erythema, eschar or edema evaluated. In the ocular irritation study, corneal opacity, area of opacity, iris, chemosis and conjunctival redness were evaluated. Results: In the cutaneous skin irritation test, all three herbal shampoos (PS9, PS20, and LS17) showed no significant erythema, eschar, or oedema formation after 72 hr of exposure and did not meet any of the irritation classification requirements. According to the Harmonized Integrated Classification System (HICS), all three herbal shampoos are classified as “Non Irritant” based on acute cutaneous testing. In the ocular irritation study, after 1, 24, 48, and 72 hr of observation, the treated eye appeared normal. There were no symptoms of systemic toxicity in any of the animals during the acclimatization and post-treatment periods. The results did not meet the irritation classification requirements for categories 1, 2A, or 2B because the treated animals had corneal opacity of 0.00, iris lesions of 0.00, conjunctival redness of 0.00, and chemosis of 0.00. Based on ocular irritation studies, all three herbal shampoos are classified as “Not Irritant” by HICS. The body weights of all the animals were within the typical range of variation for this species, strain, and age. All of the animals gained weight towards the end of the experiments. Conclusion: The acute cutaneous and ocular irritation studies indicated that three herbal shampoos (PS9, PS20, and LS17) were not irritant to the rabbit skin or eyes, indicating that they can be used in humans without irritation to the skin or eye. Key words: Herbal shampoo, Ocular irritation, Acute dermal, New Zealand white rabbits, Erythema.

The fabrication and assessment of mosquito repellent cream for outdoor protection

Mosquito-borne infections like dengue, malaria, chikungunya, etc. are a nuisance and can cause profound discomfort to people. Due to the objectional side effects and toxicity associated with synthetic pyrethroids, N,N-diethyl-3-methylbenzamide (DEET), N,N-diethyl phenylacetamide (DEPA), and N,N-di ethyl benzamide (DEBA) based mosquito repellent products, we developed an essential oil (EO) based mosquito repellent cream (EO-MRC) using clove, citronella and lemongrass oil. Subsequently, a formulation characterization, bio-efficacy, and safety study of EO-MRC were carried out. Expression of Anti-OBP2A and TRPV1 proteins on mosquito head parts were studied by western blotting. In-silico screening was also conducted for the specific proteins. An FT-IR study confirmed the chemical compatibility of the EOs and excipients used in EO-MRC. The thermal behaviour of the best EOs and their mixture was characterized by thermogravimetric analysis (TGA). GC–MS examination revealed various chemical components present in EOs. Efficacy of EO-MRC was correlated with 12% N,N-diethyl benzamide (DEBA) based marketed cream (DBMC). Complete protection time (CPT) of EO-MRC was determined as 228 min. Cytotoxicity study on L-132 cell line confirmed the non-toxic nature of EO-MRC upon inhalation. Acute dermal irritation study, acute dermal dose toxicity study, and acute eye irritation study revealed the non-toxic nature of EO-MRC. Non-target toxicity study on Danio rerio confirmed EO-MRC as safer for aquatic non-target animals. A decrease in the concentration of acetylcholinesterase (AChE) was observed in transfluthrin (TNSF) exposed Wistar rats. While EO-MRC did not alter the AChE concentrations in the exposed animals. Results from western blotting confirmed that Anti-OBP2A and TRPV1 proteins were inhibited in TNSF exposed mosquitoes. Mosquitoes exposed to EO-MRC showed a similar expression pattern for Anti-OBP2A and TRPV1 as the control group. In silico study revealed eight identified compounds of the EOs play significant roles in the overall repellency property of the developed product. The study emphasizes the mosquito repellent activity of EO-MRC, which could be an effective, eco-friendly, and safer alternative to the existing synthetic repellents for personal protection against mosquitoes during field conditions.

Formulation of Cinchona Extract (Cinchona succirubra) Cream and The Safety as Hair Fertilizer

Background: cinchona extract contains quinoline alkaloids, has telangiectatic activity, is practically insoluble in water so penetration into hair follicles is low and requires a delivery system, namely cream. Objective: to determine the formula of cinchona extract cream with good activity, physical stability and safety. Methodology: cinchona bark extraction (soxhletation method), phytochemical screening, cinchona extract dosage determination, optimization of cream formula using Design Expert software version 11. Evaluation: pH, adhesion, spreadability, viscosity and cycling test stability. Activity test using guinea pigs (Cavia porcellus) for 14 days, parameters of hair length/2 days, hair mass (14th day). Acute dermal irritation test using rabbit (Orycogalus cuniculus) by erythema and edema index parameters. Results: cinchona extract (13.32% yield) contained quinoline alkaloids, cinchona extract dosage was 20% (p&lt;0.05). The optimum formula is F2 with characteristics: pH 6.48±0.07, adhesion 1.16±0.07, spreadability 4.99±0.85 and viscosity 3067±416.45, has good physical stability. Activity test: test area hair length 13.54 – 62.14% longer than normal control and 10.10 – 49.17% than negative control. The hair mass of test area was 122.91% heavier than normal control and 104.48% of negative control (p&lt;0.05). Cinchona extract and excipients were non-irritant. Conclusion: Cinchona extract cream (20%) has hair fertilizer activity, good physical stability and safety.

Acute toxicity and 28-day repeated dose studies of multi-walled carbon nanotubes

In the light of the increased production and use of multi-walled carbon nanotube (MWCNT) in consumer products, there is a need for screening the potential toxicity of this nanomaterial. In the present study, the researchers have investigated the acute dermal and acute eye irritation in rabbits and acute oral irritation and 28-day repeated administration of MWCNT in rats. A single dose of 5000 mg/kg was used to test Albino Rabbits for acute dermal and eye irritation test. Similar dose was given to Sprague Dawley Rats for the acute oral and 28-day repeated dose test. Clinical signs/manifestations were closely observed for the first four (4) hours post sample administration and was continued for 1,2,3,7 and 14-day observation period. In acute toxicity study, no treatment-related death or toxic signs were observed with MWCNT. In the 28-day repeated dose study, no significant differences in hematology and clinical biochemistry were detected between control and MWCNT. However, histopathology results revealed mild periarteriolar lymphoid cell depletion in the spleen and mild tubular cell degeneration on the cortex and medulla of both kidneys of the rats while no remarkable lesions were seen on the other organs of both female and male rats.

A study on the acute dermal irritation of a novel polyherbal anesthetic formulation for parenteral administration in wistar albino rats

A study on the acute dermal irritation of a novel polyherbal anesthetic formulation for parenteral administration in wistar albino rats

Safety assessment of a novel water-soluble extract of Boswellia serrata gum resin: acute toxicity, 90-day sub-chronic toxicity, Ames’ bacterial reverse mutation, and in vivo micronucleus assays

Boswellia serrata gum resin extracts have demonstrated potential benefits in alleviating joint pain and discomfort of osteoarthritis. The major objective of the present study was to assess the safety of a water-soluble B. serrata gum resin extract (LI51202F1) in diverse models of acute oral, acute dermal, primary dermal irritation, eye irritation, and 90-day sub-chronic repeated dose toxicity studies, as well as Ames’ bacterial reverse mutation assay and in vivo micronucleus assay. The acute oral and dermal toxicity studies in Sprague Dawley (SD) rats demonstrated that the median lethal dose (LD50) of LI51202F1 is >2000 mg/kg body weight (BW). The acute dermal and eye irritation tests in New Zealand white rabbits exhibited that LI51202F1 is non-irritating to the skin and mildly irritating to the eyes, respectively. The 90-days sub-chronic repeated oral dose study demonstrated that the LI51202F1-treated male and female SD rats did not show signs of toxicity on their BW, food intake, organ weights, thyroid hormones, and on the clinical pathology, gross pathology, and histopathological assessments. In male and female rats, the no-observed-adverse-effect level (NOAEL) of LI51202F1 was 500 mg/kg/day, the highest tested dose in the study. The results of the bacterial reverse mutation assay in Salmonella typhimurium TA98, TA100, TA1535, TA1537, and Escherichia coli WP2uvrA (pKM101) strains in the presence or absence of S9 metabolic activation system and a micro-nucleus assay in mouse bone marrow erythrocytes demonstrated that LI51202F1 is neither mutagenic nor clastogenic. In conclusion, under the conditions of these studies, LI51202F1 demonstrated broad-spectrum safety.